Clinical trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine…
NCT00168428 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00168428 |
|---|---|
| Title | A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine Disorders |
| Intervention type | Biological, Other |
| Interventions | Botulinum Toxin Type A, placebo (saline) |
| Enrollment | 705 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Aug 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 18, 2013 |
| Countries | Canada, Croatia, Germany, Switzerland, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: